CLINICAL AND HEALTH OUTCOMES ASSOCIATED WITH TREATMENT SEQUENCES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS

Marla C. Dubinsky  1     Simone Rivolo  2     Manasi Suryavanshi  3     Apoorva Ambavane  3     Neeharika Agnihotri  3     Conrado Franco-Villalobos  3     Mark T. Osterman  3     Komal Gupte-Singh  3    
1 Icahn School of Medicine at Mount Sinai, New York City, United States
2 Evidera, Inc., London, United Kingdom
3 Bristol Myers Squibb, Princeton, United States

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing